From macro- to microcirculation: benefits in hypertension and diabetes

Area of Science:

• Cardiovascular Medicine
• Nephrology
• Endocrinology

Background:

• Chronic hypertension and diabetes mellitus induce macrovascular and microvascular changes.
• Arterial stiffness elevates central pressures, increasing left ventricular afterload and reducing coronary blood flow.
• Resistance artery remodeling and capillary rarefaction exacerbate hypertension and arterial stiffening effects.

Purpose of the Study:

• To investigate the vascular pathophysiological changes associated with chronic hypertension and diabetes.
• To explore the therapeutic potential of vasodilating antihypertensive agents in mitigating these vascular alterations.

Main Methods:

• The study reviews the pathophysiological mechanisms linking hypertension, diabetes, and vascular damage.
• It examines the effects of vasodilating antihypertensive drugs, specifically the perindopril/indapamide combination, on vascular remodeling.

Main Results:

• Greater arterial stiffness leads to increased central systolic and pulse pressure, impacting left ventricular afterload and coronary perfusion.
• Resistance artery remodeling and capillary rarefaction contribute to elevated peripheral resistance and amplify hemodynamic stress.
• Therapeutic intervention with perindopril/indapamide modifies arterial and arteriolar remodeling, reducing central systolic blood pressure and improving vascular bed perfusion.

Conclusions:

• Chronic hypertension and diabetes precipitate target organ damage, including left ventricular hypertrophy and coronary artery disease.
• Vasodilating antihypertensive medications, like perindopril/indapamide, can reverse detrimental vascular remodeling.
• These vascular benefits likely explain the observed reductions in cardiovascular morbidity and mortality with such treatments.